Publications by authors named "Alba Brandes"

Claim this Profile
C
Concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma (CATNON; EORTC study 26053-22054): final and exploratory analyses of a randomised, open-label, phase 3 trial.
Martin J van den Bent, Santoesha A Ghisai, Wolfgang Wick, Marc Sanson, Alba Ariela Brandes

Lancet Oncol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emerging strategies and advances in the management of sinonasal carcinoma.
Alicia Tosoni, Maria Pia Foschini, Ernesto Pasquini, Elisa D'Angelo, Vincenzo Di Nunno, Alba Ariela Brandes

Expert Rev Anticancer Ther· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health-related quality of life in patients with progressive glioblastoma treated with combined bevacizumab and lomustine versus lomustine only: Secondary outcome of the randomized phase III EORTC 26101 study.
Linda Dirven, Abigirl Machingura, Martin J van den Bent, Corneel Coens, Andrew Bottomley, Alba A Brandes

Neurooncol Pract· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epigenetic landscape reorganisation and reactivation of embryonic development genes are associated with malignancy in IDH-mutant astrocytoma.
Santoesha A Ghisai, Levi van Hijfte, Wies R Vallentgoed, C Mircea S Tesileanu, Iris de Heer, Alba A Brandes

Acta Neuropathol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deep-learning-based reconstruction of undersampled MRI to reduce scan times: a multicentre, retrospective, cohort study.
Aditya Rastogi, Gianluca Brugnara, Martha Foltyn-Dumitru, Mustafa Ahmed Mahmutoglu, Chandrakanth J Preetha, Alba A Brandes

Lancet Oncol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epigenetic landscape reorganization and reactivation of embryonic development genes are associated with malignancy in IDH-mutant astrocytoma.
Santoesha A Ghisai, Levi van Hijfte, Wies R Vallentgoed, C Mircea S Tesileanu, Iris de Heer, Alba A Brandes

bioRxiv· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Markers of DNA Methylation and Next-Generation Sequencing in Progressive Glioblastoma from the EORTC-26101 Trial.
Tobias Kessler, Daniel Schrimpf, Laura Doerner, Ling Hai, Leon D Kaulen, Alba A Brandes

Clin Cancer Res· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glioblastoma treatment slowly moves toward change: novel druggable targets and translational horizons in 2022.
Lidia Gatto, Enrico Franceschi, Alicia Tosoni, Vincenzo Di Nunno, Stefania Bartolini, Alba Ariela Brandes

Expert Opin Drug Discov· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiotherapy combined with nivolumab or temozolomide for newly diagnosed glioblastoma with unmethylated MGMT promoter: An international randomized phase III trial.
Antonio Omuro, Alba A Brandes, Antoine F Carpentier, Ahmed Idbaih, David A Reardon

Neuro Oncol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thrombocytopenia limits the feasibility of salvage lomustine chemotherapy in recurrent glioblastoma: a secondary analysis of EORTC 26101.
Emilie Le Rhun, Felix Boakye Oppong, Martin van den Bent, Wolfgang Wick, Alba A Brandes

Eur J Cancer· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How to treat histone 3 altered gliomas: molecular landscape and therapeutic developments.
Vincenzo Di Nunno, Enrico Franceschi, Lidia Gatto, Alicia Tosoni, Stefania Bartolini, Alba Ariela Brandes

Expert Rev Clin Pharmacol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors associated with health-related quality of life (HRQoL) deterioration in glioma patients during the progression-free survival period.
Marijke B Coomans, Linda Dirven, Neil Aaronson, Brigitta G Baumert, Martin van den Bent, Alba A Brandes

Neuro Oncol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Beyond Imaging and Genetic Signature in Glioblastoma: Radiogenomic Holistic Approach in Neuro-Oncology.
Lidia Gatto, Enrico Franceschi, Alicia Tosoni, Vincenzo Di Nunno, Caterina Tonon, Alba Ariela Brandes

Biomedicines· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
J
Joint Final Report of EORTC 26951 and RTOG 9402: Phase III Trials With Procarbazine, Lomustine, and Vincristine Chemotherapy for Anaplastic Oligodendroglial Tumors.
Andrew B Lassman, Khê Hoang-Xuan, Mei-Yin C Polley, Alba A Brandes, J Gregory Cairncross

J Clin Oncol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corticosteroids use and neurocognitive functioning in patients with recurrent glioblastoma: Evidence from European Organization for Research and Treatment of Cancer (EORTC) trial 26101.
Ivan Caramanna, Julie M de Kort, Alba A Brandes, Walter Taal, Michael Platten

Neurooncol Pract· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hypermutation as a potential predictive biomarker of immunotherapy efficacy in high-grade gliomas: a broken dream?
Lidia Gatto, Enrico Franceschi, Alicia Tosoni, Vincenzo Di Nunno, Stefania Bartolini, Alba Ariela Brandes

Immunotherapy· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor-Associated Microenvironment of Adult Gliomas: A Review.
Vincenzo Di Nunno, Enrico Franceschi, Alicia Tosoni, Lidia Gatto, Stefania Bartolini, Alba Ariela Brandes

Front Oncol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Temozolomide and Radiotherapy versus Radiotherapy Alone in Patients with Glioblastoma, IDH-wildtype: Post Hoc Analysis of the EORTC Randomized Phase III CATNON Trial.
C Mircea S Tesileanu, Marc Sanson, Wolfgang Wick, Alba A Brandes, Paul M Clement

Clin Cancer Res· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacotherapeutic Treatment of Glioblastoma: Where Are We to Date?
Lidia Gatto, Vincenzo Di Nunno, Enrico Franceschi, Alicia Tosoni, Stefania Bartolini, Alba Ariela Brandes

Drugs· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular Characterization of Pancreatic Ductal Adenocarcinoma Using a Next-Generation Sequencing Custom-Designed Multigene Panel.
Deborah Malvi, Francesco Vasuri, Thais Maloberti, Viviana Sanza, Antonio De Leo, Alba A Brandes

Diagnostics (Basel)· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glioblastoma Microenvironment: From an Inviolable Defense to a Therapeutic Chance.
Vincenzo Di Nunno, Enrico Franceschi, Alicia Tosoni, Lidia Gatto, Stefania Bartolini, Alba Ariela Brandes

Front Oncol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and Molecular Features of Patients with Gliomas Harboring IDH1 Non-canonical Mutations: A Systematic Review and Meta-Analysis.
Vincenzo Di Nunno, Enrico Franceschi, Alicia Tosoni, Lidia Gatto, Ilaria Maggio, Alba Ariela Brandes

Adv Ther· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasmatic MMP9 released from tumor-infiltrating neutrophils is predictive for bevacizumab efficacy in glioblastoma patients: an AVAglio ancillary study.
Carine Jiguet-Jiglaire, Sebastien Boissonneau, Emilie Denicolai, Victoria Hein, Romain Lasseur, Alba A Brandes

Acta Neuropathol Commun· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular Targeted Therapies: Time for a Paradigm Shift in Medulloblastoma Treatment?
Lidia Gatto, Enrico Franceschi, Alicia Tosoni, Vincenzo Di Nunno, Stefania Bartolini, Alba Ariela Brandes

Cancers (Basel)· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to: Impact of lymphopenia on survival for elderly patients with glioblastoma: A secondary analysis of the CCTG CE.6 (EORTC 26062-22061, TROG 08.02) randomized clinical trial.
Andrew J Song, Keyue Ding, Iyad Alnahhas, Normand J Laperriere, James Perry, Alba A Brandes

Neurooncol Adv· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis